Crossmark

Correction to: Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models

Crossref DOI link: https://doi.org/10.1007/s11307-021-01640-x

Published Online: 2021-08-16

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liapis, Vasilios https://orcid.org/0000-0002-2354-3521
Tieu, William https://orcid.org/0000-0002-7161-4152
Wittwer, Nicole L. https://orcid.org/0000-0002-2331-5799
Gargett, Tessa https://orcid.org/0000-0003-3713-1373
Evdokiou, Andreas https://orcid.org/0000-0001-8321-9806
Takhar, Prab

Rudd, Stacey E. https://orcid.org/0000-0001-9996-8561
Donnelly, Paul S. https://orcid.org/0000-0001-5373-0080
Brown, Michael P. https://orcid.org/0000-0002-5796-1932
Staudacher, Alexander H. https://orcid.org/0000-0001-5034-9532
License Information

Text and Data Mining valid from 2021-08-16

Version of Record valid from 2021-08-16
More Information

Article History

First Online: 16 August 2021

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below